← All comparisons
Head-to-head · FAERS comparison

Losartan vs Ramipril: side effects in FDA adverse event reports

Losartan profile · Ramipril profile · data 2026-09-14
How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

LosartanRamipril
Drug class–Angiotensin Converting Enzyme Inhibitor
Brand namesLosartan Potassium–
FAERS reports173,627123,136
Serious63%93%
Death outcome12,52213,282
Boxed warningYes FETAL TOXICITY When pregnancy is detected, discontinue losartan potassium tablets as soon as possible. Drugs that act directly on the renin-angiotensin system cYes FETAL TOXICITY WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning When pregnancy is detected, discontinue ramipril as soon as p

Signals both drugs share

No strong shared signal after removing coding and lab terms.

Labeled signals distinctive to Losartan

Labeled signals distinctive to Ramipril

Common questions

Which has more reported side effects, Losartan or Ramipril?

Losartan has 173,627 FAERS reports and Ramipril 123,136. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (63% vs 93%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Losartan and Ramipril share?

They share no strong flagged signal after artifacts and lab terms are removed.

Is Losartan or Ramipril safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.